Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Tumour Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05012371
What this trial is testing

Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more
M.D. Anderson Cancer Center 90
Testing effectiveness (Phase 2)UnknownNCT02617134
What this trial is testing

CAR-T Cell Immunotherapy in MUC1 Positive Solid Tumor

Who this might be right for
Malignant Glioma of BrainColorectal CarcinomaGastric Carcinoma
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT01160744
What this trial is testing

Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Eli Lilly and Company 280
Testing effectiveness (Phase 2)Looking for participantsNCT06301165
What this trial is testing

TPC Versus GP Induction Chemotherapy for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 162
Large-scale testing (Phase 3)Looking for participantsNCT07647328
What this trial is testing

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

Who this might be right for
ER-Positive HER2-Negative Breast Cancer
AstraZeneca 150
Testing effectiveness (Phase 2)Ended earlyNCT04258111
What this trial is testing

IBI310 in Combination with Sintilimab in Patients with DNA Mismatch Repair Deficient (dMMR)/microsatellite Instability High (MSI-H) Locally-advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Innovent Biologics (Suzhou) Co. Ltd. 4
Not applicableStudy completedNCT03500471
What this trial is testing

Robotic and Laparoscopic Total Gastrectomy With D2 Lymphadenectomy for Locally Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Southwest Hospital, China 142
Large-scale testing (Phase 3)UnknownNCT03008109
What this trial is testing

Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLC

Who this might be right for
Advanced CancerLung Cancer, Nonsmall Cell
Zaiwen Fan 80
Post-approval studies (Phase 4)Not Yet RecruitingNCT07589699
What this trial is testing

Trastuzumab Rezetecan (T-DXh) in HER2+ Breast Cancer With Non-pCR After TCbHP

Who this might be right for
Breast CancerHER2-positive Breast CancerEarly-stage Breast Cancer+1 more
The First Affiliated Hospital with Nanjing Medical University 59
Testing effectiveness (Phase 2)Study completedNCT00103311
What this trial is testing

SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IIIA Colon Cancer+9 more
National Cancer Institute (NCI) 64
Early research (Phase 1)Study completedNCT05303493
What this trial is testing

Camu-Camu Prebiotic and Immune Checkpoint Inhibition in Patients With Non-small Cell Lung Cancer and Melanoma

Who this might be right for
NSCLC Stage IVMelanoma Stage IVUnresectable Melanoma+1 more
Centre hospitalier de l'Université de Montréal (CHUM) 45
Not applicableLooking for participantsNCT06975384
What this trial is testing

The Associations of Sleep Disturbance With Therapy Efficacy and Prognosis of Lung Cancer

Who this might be right for
Lung CancerSleep DisturbanceImmune Checkpoint Inhibitors+1 more
Second Xiangya Hospital of Central South University 1,270
Testing effectiveness (Phase 2)Study completedNCT01435252
What this trial is testing

A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab

Who this might be right for
Oropharyngeal CancerHypopharyngeal CancerLaryngeal Cancer
University of Zurich 68
Early research (Phase 1)Study completedNCT01059552
What this trial is testing

Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Locally Advanced Non-small Cell Lung Cancer
Fox Chase Cancer Center 18
Not applicableLooking for participantsNCT04792684
What this trial is testing

Collection of Samples USOPTIVAL Study

Who this might be right for
Colorectal Cancer (CRC)Advanced Adenomas (AA)
Universal Diagnostics 1,300
Testing effectiveness (Phase 2)Study completedNCT00373906
What this trial is testing

Velcade in MALT Lymphoma Patients

Who this might be right for
MALT Lymphoma
Medical University of Vienna 16
Testing effectiveness (Phase 2)Ended earlyNCT06682806
What this trial is testing

PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation

Who this might be right for
Advanced Solid TumorEsophageal CancerMetastatic Solid Tumor+2 more
Prelude Therapeutics Incorporated 6
Testing effectiveness (Phase 2)Looking for participantsNCT05451784
What this trial is testing

Treatment of Advanced or Metastatic Triple-negative Breast Cancer With Adoptive Therapy of PD1+ TILS

Who this might be right for
Metastatic Triple-Negative Breast Carcinoma
Fundacio Clinic Barcelona 20
Early research (Phase 1)Active Not RecruitingNCT02715284
What this trial is testing

Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors

Who this might be right for
Neoplasms
Tesaro, Inc. 729
Not applicableStudy completedNCT04181333
What this trial is testing

Safety and Efficacy of Trastuzumab BS

Who this might be right for
Gastric Cancer
Pfizer 8
Next Page